Page 3 - Nathanaels Gray News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nathanaels gray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nathanaels Gray Today - Breaking & Trending Today

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Expected to Announce Earnings of -$0.48 Per Share

Analysts forecast that Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) will report ($0.48) earnings per share for the current quarter, according to Zacks. Five analysts have issued estimates for Syros Pharmaceuticals’ earnings. The highest EPS estimate is ($0.45) and the lowest is ($0.51). Syros Pharmaceuticals posted earnings per share of ($0.23) in the same quarter […] ....

United Kingdom , Hong Kong , Thomson Reuter , Jamese Bradner , Piper Sandler , Richarda Young , Nathanaels Gray , Life Insurance Co , Syros Pharmaceuticals , Zacks Investment Research , Syros Pharmaceuticals Get Rating , Invesco Ltd , Syros Pharmaceuticals Inc , Citigroup Inc , Hong Kong Ltd , Get Rating , Syros Pharmaceutical , Investment Research , Kong Ltd , Nasdaq Syrs ,

$4.56 Million in Sales Expected for Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) This Quarter

Wall Street brokerages expect Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) to announce sales of $4.56 million for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Syros Pharmaceuticals’ earnings. The lowest sales estimate is $3.10 million and the highest is $5.85 million. Syros Pharmaceuticals reported sales of $4.83 million in the […] ....

United Kingdom , Hong Kong , Jamese Bradner , Piper Sandler , Richarda Young , Nathanaels Gray , Life Insurance Co , Syros Pharmaceuticals , Zacks Investment Research , Syros Pharmaceuticals Get Rating , Syros Pharmaceuticals Inc , Wells Fargo Company , Citigroup Inc , Hong Kong Ltd , Wall Street , Get Rating , Syros Pharmaceutical , Investment Research , Kong Ltd , Wells Fargo , Nasdaq Syrs ,

$5.65 Million in Sales Expected for Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) This Quarter

$5.65 Million in Sales Expected for Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) This Quarter
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Jamese Bradner , Piper Sandler , Richarda Young , Nathanaels Gray , York Mellon Corp , Syros Pharmaceuticals Inc , Syros Pharmaceuticals Company Profile , Syros Pharmaceuticals , Zacks Investment Research , Capital Partners , Syros Pharmaceutical , Investment Research , New York Mellon Corp , Capital Management ,